Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- 217-Mdd-302 No ClinicalTrials.gov identifier reported
- 217-Mdd-303 No ClinicalTrials.gov identifier reported
- 217-Mdd-304 No ClinicalTrials.gov identifier reported
- 218046 No ClinicalTrials.gov identifier reported
- 21824_Shveta Gupta, MD No ClinicalTrials.gov identifier reported
- 218313 No ClinicalTrials.gov identifier reported
- 218682 No ClinicalTrials.gov identifier reported
- 219582 No ClinicalTrials.gov identifier reported
- 21Sust071 No ClinicalTrials.gov identifier reported
- 21Sust076 No ClinicalTrials.gov identifier reported
- 21Wlu001 No ClinicalTrials.gov identifier reported
- 2204 NCT02150967
- 221001 No ClinicalTrials.gov identifier reported
- 22-109 No ClinicalTrials.gov identifier reported
- 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease No ClinicalTrials.gov identifier reported
- 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease No ClinicalTrials.gov identifier reported
- 22267 DMC Agreement - Helena Wachslicht Rodbard, MD No ClinicalTrials.gov identifier reported
- 22267 DMC Chairperson Agreement - Silvio Inzucchi MD No ClinicalTrials.gov identifier reported
- 22267 - Dr. Jay S. Sklyer Steering Committee No ClinicalTrials.gov identifier reported
- 22267 - Dr. Katherine R. Tuttle No ClinicalTrials.gov identifier reported
- 22267 - Sylvia Rosas No ClinicalTrials.gov identifier reported
- 22285 No ClinicalTrials.gov identifier reported
- 22-322 No ClinicalTrials.gov identifier reported
- 22453 REFINE-IO Cedars-Sinai Medical Center CTA_Ju Dong Yang, MD No ClinicalTrials.gov identifier reported
- 22453 REFINE-IO Mercy Medical Center CTA_Anurag Maheshwari, MD No ClinicalTrials.gov identifier reported
- 22453 REFINE-IO Regents of the University of Michigan CTA_Neehar Parikh, MD No ClinicalTrials.gov identifier reported
- 22453 REFINE-IO Southern Arizona VA Health Care System CTA_Thomas Hanzlik, MD No ClinicalTrials.gov identifier reported
- 22453 REFINE-IO Thomas Jefferson University CTA_Richard Kalman, MD No ClinicalTrials.gov identifier reported
- 22615_DMC Agreement_Belani No ClinicalTrials.gov identifier reported
- 22776 Steering Committee Chairperson - Todd Herrington MD, PhD No ClinicalTrials.gov identifier reported
- 22GI-Glymphatic Modulation No ClinicalTrials.gov identifier reported
- 22Plm015 No ClinicalTrials.gov identifier reported
- 22Q11.2 DS No ClinicalTrials.gov identifier reported
- 23-006988 OLP-II Registry No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported
- 2-(3-{1-Carboxy-5-[(6-18F-Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid (Pyl) in Patients With High Risk and Biochemically Recurrent Prostate Cancer No ClinicalTrials.gov identifier reported